arrow
N

Natasha S. Anstee

walter & eliza hall institute
H指数:16
被引数:1,332

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD74 Antibody Conjugated to an MCL1 Inhibitor (S227928) Combines Synergistically with Venetoclax to Enhance Killing of Acute Myeloid Leukemia

CD74抗体与MCL1抑制剂(S227928)偶联后,与Venetoclax联合作用可协同增强急性髓系白血病的杀伤效果。

BLOOD
IF23.1
2024-11-050
PRE
A Phase II Randomized Trial Comparing Low-Dose Cytarabine and Venetoclax plus /- Midostaurin in Non-Adverse Cytogenetic Risk Acute Myeloid Leukemia: The ALLG AMLM25 Intervene Trial

一项比较低剂量阿糖胞苷和维奈克拉联合/不联合米哚妥林治疗非不良染色体风险急性髓系白血病的II期随机试验:ALLG AMLM25干预试验

BLOOD
IF23.1
2024-11-050
PRE
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia

C/ebp α 赋予FLT3-Mutant白血病对脂肪酸合成代谢途径的依赖性和对脂质氧化应激诱导的铁死亡的脆弱性

2023-04-0333
OA
Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer (vol 25, pg 641, 2019)
2022-02-184
OA
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

血小板gpib α 是NASH和随后的肝癌的中介和潜在的干预靶点

2019-04-01285
OAAI
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo
2017-03-31113
OAAI